|
|
|
|
|
by jzwinck
2352 days ago
|
|
We in the east are well aware that we benefit in some ways from the extremely risk averse regulators in the US and Europe and others. It's often explicitly acknowledged with labels like "treatment developed in the US" though it can also be hard to separate the real from the false claims of such. On the other hand, not only does the east manufacture many of the pharmaceuticals sold in the west, it is a vast market which provides additional revenue with a convenient geographical separation which is difficult to arbitrage (Ibuprofen costs nothing in India compared to the US, but you don't see Indians flying to the US with suitcases of pills for sale). |
|